Recently added

A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC

Ahn, Myung-Ju; Lisberg, Aaron; Sands, Jacob; Goto, Yasushi; Hong, Min Hee; Paz-Ares, Luis; FELIP, ENRIQUETA (Elsevier, 2025-11)

Breastfeeding after breast cancer in young BRCA carriers

DELUCCHI, VIRGINIA; Ferrari, Alberta; Blondeaux, Eva; Mariamidze, Elene; Bernstein Molho, Rinat; Frank, Sophie; Balmaña, Judith (Oxford University Press, 2025-11)

Individualization of Donor Nerve Selection With Intraoperative Nerve Monitoring in Axillary Nerve Neurotization

Tarnawski Español, Guillermo-José; Morro-Martí, Maria Rosa; Llusa, Manuel; Fernández-Conejero, Isabel; Benitez Flores, Julia; Ortega-Centol, Aritz (Elsevier, 2025-11)

Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

Diego, Daniela S.; Kammler, Roswitha; Demeestere, Isabelle; Niman, Samuel; Partridge, Ann; Ruggeri, Monica; Saura Manich, Cristina (Elsevier, 2025-12)

Real-world evidence from the Global aHUS Registry confirms the safety and effectiveness of switching to ravulizumab from eculizumab in patients with aHUS: a plain language summary

Al-Dakkak, Imad; Schaefer, Franz; Greenbaum, Larry; Ariceta Iraola, Gema (Informa UK Limited, 2025)

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Hospital Universitari - HVH: Recent submissions

A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC

Breastfeeding after breast cancer in young BRCA carriers

Individualization of Donor Nerve Selection With Intraoperative Nerve Monitoring in Axillary Nerve Neurotization

Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

Real-world evidence from the Global aHUS Registry confirms the safety and effectiveness of switching to ravulizumab from eculizumab in patients with aHUS: a plain language summary

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Hospital Universitari - HVH: Recent submissions

A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC ﻿

Breastfeeding after breast cancer in young BRCA carriers ﻿

Individualization of Donor Nerve Selection With Intraoperative Nerve Monitoring in Axillary Nerve Neurotization ﻿

Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547] ﻿

Real-world evidence from the Global aHUS Registry confirms the safety and effectiveness of switching to ravulizumab from eculizumab in patients with aHUS: a plain language summary ﻿

A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC

Breastfeeding after breast cancer in young BRCA carriers

Individualization of Donor Nerve Selection With Intraoperative Nerve Monitoring in Axillary Nerve Neurotization

Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

Real-world evidence from the Global aHUS Registry confirms the safety and effectiveness of switching to ravulizumab from eculizumab in patients with aHUS: a plain language summary